Epidemiological data and family studies in autism show that there is a genetic susceptibility factor in the aetiology of this syndrome. We carried out an association study in infantile autism. Two markers of the homeogene EN2 involved in cerebellar development were tested in a population of 100 autistic children and in a population of 100 control children. With the MP4 probe showing a PvuII polymorphism, significant differences in the allele frequencies between the two populations were found (x2=7-99, df=1, p<OOl). With the MP5 probe showing an SstI polymorphism, no difference appeared (x2= 1X17, not significant). Several clinical examinations allowed us to characterise the autistic children. Most of them had high scores for autistic behaviour and language disorders but low scores for neurological syndromes. Two children had a significant family history and six children had confirmed syndromes or diseases of genetic origin. Discrim'inant analysis between clinical and molecular data did not give significant results.
Infantile autism, first described by Kanner' in 1943 , is an early behavioural disorder principally characterised by an incapacity for verbal or non-verbal communication and by a deficit in emotional relations. The aetiology of this syndrome is still unknown but is probably multifactorial.2 Autism is defined by the international classification DSM III-R3 as a pervasive developmental disorder.
The involvement of the central nervous system (CNS) and of its development in the pathophysiology of autism has been studied for several decades. The symptoms observed in this syndrome may involve different cerebral structures. 4 Several authors have suggested disturbances in the CNS, particularly in the connections of the brainstem, of the cerebellum, [5] [6] [7] [8] and in the connections of the limbic system.9'"
Other studies have also considered the involvement of the cortical association area, including the frontal lobes, and neural connections within and between brain regions. [12] [13] [14] More recently, a cerebellar hypothesis has been proposed: the cerebellum controls motility"5 and regulation of perception.16 In 1988 Courchesne et al reported hypoplasia of lobules VI and VII of the cerebellar vermis in 14 autistic subjects. Histological studies of the cerebellum have also shown abnormalities, the characteristics of which suggest that they are the consequence of a curtailment of the development of portions of the limbic system and cerebellar circuits." [7] [8] [9] These results indicate the possibility of mutations of genes involved in the development of these structures.
Results of epidemiological and family studies in autism have shown that there is a genetic susceptibility factor in this syndrome and a significant sex difference was observed with a pooled male-female ratio of approximately 3:1.20 Moreover, the prevalence of autism was greater in sibs when one child was already affected.21 Finally, twin studies showed that concordance rates for monozygotic twins were greater than for dizygotic twins.22-24 Association and linkage studies in autism with several markers did not give convincing results. However, the possible association of two markers of the c-Harvey-ras oncogene with autism has been identified. 25 26 These various data encourage consideration of developmental genes of the CNS, and the genes with homeobox look particularly interesting. 27 These genes encode for a basic homeoprotein which has the property of binding DNA. Therefore the products of homeogenes may have a role in the regulation of the expression of other genes. More precisely, the homeobox peptides might regulate important events in the morphological differentiation of the postmitotic neurone.2' The "engrailed" and "invected" homeogenes are segmentation genes in Drosophila and have homologous genes in the mouse, En-i and En-2.
These two genes are expressed in the cerebellum of fetal and adult mice.2930 Moreover, abnormal foliation was observed in the adult cerebellum of a mouse in which the En-2 gene had been partly deleted.3" Human homologous EN-1 and EN-2 genes are located on chromosome 7 (q36-qter) and on chromosome 2 (qi 3-q2 1) respectively. '2 33 In this association study with 100 autistic and 100 control children, two probes of the EN-2 gene were used. The first probe, MP4, is located within the 5' region of the EN-2 gene. ' 43 Each of these four evaluations were rated from none (1) to profound (5) for the 100 autistic children.
Clinical evaluation was completed by using a behaviour rating scale (Behavior Summarized Evaluation: BSE scale4445) which supplies information on the current behaviour ofthe child. It consists of 29 items rated on a five point scale ranging from never (1) to always (5) . Day patients from the Child Psychiatry Day Care Unit of the CHRU of Tours were rated once a week by two independent observers who conferred on the weekly ratings to produce the final score. These two observers were nurses who had known the children for several months and who had daily contact with them. The other children were rated during two days by two independent observers, expert in evaluating autistic children. For the children under 3 years old, a scale very similar to the BSE scale, the Infant Behaviour Summarized Evaluation Scale (I-BSE), was used. 46 one way analysis of variance (ANOVA) was performed. SPSS subprograms were used.
Results

CLINICAL RESULTS
The distribution of scores for autistic behaviour, cognitive disorders, neurological syndromes, and language disorders in the population of 100 autistic children were as follows: 76 children had high scores ( MP5 (X2 = 0 51, df= 1, NS).
RELATIONSHIP BETWEEN CLINICAL AND GENETIC RESULTS
The distribution of the MP4 probe was analysed according to family history, genetic somatic signs, results of clinical examinations, and the intensity of scores in each of these categories. The same difference in allele distribution was always observed between the normal and the autistic population whatever the scores in family history: if children with score 5 were excluded from the comparison, the difference remained (X2 = 6-07, df= 1, p<0Q02).
When the children with score 5 for somatic genetic signs were excluded, the x2 value was less significant (X2=4487, df= 1, p<0 05).
As most of the children had high scores in autistic behaviour and low scores in neurological disorders, our sample could be divided into three groups according to their cognitive functioning: group I (25 children) with mild impairment (score 1 and 2), group II (31 children) with moderate impairment (score 3), and group III (44 children) with severe impairment (scores 4 and 5). There was no significant difference between clinical groups I, II, and III for allele distribution. If we considered the three groups of patients (table 3) determined by their genotype for the MP4 probe (homozygous 1-1: 14 children, homozygous 2-2: 42 children, and heterozygous 1-2: 44 children), no more significant difference appeared between these three groups for clinical data.
The three "genotypical" groups did not correspond to the three "clinical" groups.
Moreover, discriminant analysis was performed between the three "genotypical" groups and the scores for autistic behaviour, cognitive syndrome, neurological syndromes, and language disorders. None of the scores for each of four evaluations allowed discrimination of the three genotypes. We also compared the allele distribution for each evaluation between children with scores 1, 2, and 3 and those with scores 4 and 5. The results were not significant (autistic behaviour: x2 = 0.55, NS; cognitive disorders: x2= 19, NS; neurological syndromes: X2 = 1-17, NS; language disorders: x2 = 0 15, NS).
Discriminant analysis between the three genotypes was also performed on the items of the BSE scale. Item 19 (disturbance of feeding behaviour) allowed discrimination between the three genotypes. This result was confirmed by the Kruskal-Wallis non-parametric test (X2= 13-25, p=0013 ).
Discussion
The clinical data obtained with the BSE scale and the evaluation of autistic behaviour, cognitive disorders, neurological syndromes, and language disorders confirmed the diagnosis of autism in the patient population according to DSM III-R. Relevant somatic genetic signs scored 4 and 5 were present in 13 of these 100 children. Gillberg and Wahlstrom52 found three cases ofXYY males among 55 autistic children. San Filippo syndrome has been associated with mental retardation in a case report. 53 We could not find any association of Cohen syndrome, Waardenburg syndrome, Marfan syndrome, Angelman syndrome, or FG syndrome (which is an X linked syndrome) with autism in published reports, nor association between autism and arginosuccinic acid synthetase deficiency.
Among the 100 autistic children in our study, only one child had fra(X) syndrome detected by molecular biological methods. The percentage of fra(X) subjects identified among autistic populations varies considerably according to different studies.54 Finally, one autistic girl in our population had suspected Rett syndrome. The principal common feature between Rett and autistic syndromes is the existence of stereotypic behaviours.55 However, these two syndromes have a distinct evolution in time and the results of studies by Ollson and Rett56 show important differences between them.
Eleven percent offamilies of autistic children in our study have mental retardation or psychiatric disorders or both in parents or close relatives. Aggregation of cognitive disorders and severe social deficits in the families and relatives of autistic probands has been described.57 Several studies have reported the presence of particular psychiatric disorders in the families of autistic subjects. Recurrent major affective disorder is also more common in the parents of autistic probands, although the difference compared with control subjects does not reach statistical significance.
In this association study we show that allele 2 We thank Ms C Cherpi for her technical assistance and Dr Raynaud (Department of Genetics, Pr Moraine) for her participation in diagnosis of fragile X syndrome in the autistic population.
